146 related articles for article (PubMed ID: 28516113)
21. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
Yates AJ; Oreffo RO; Mayor K; Mundy GR
J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
[TBL] [Abstract][Full Text] [Related]
22. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
23. The effect of Gu-Sui-Bu (Drynaria fortunei) on bone cell activity.
Sun JS; Thériault BL; Anderson GI
Am J Chin Med; 2004; 32(5):737-53. PubMed ID: 15633809
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of osteoclast activity and bone turnover in different skeletal sites.
Goldberg S; Grynpas MD; Glogauer M
Arch Oral Biol; 2016 Nov; 71():134-143. PubMed ID: 27505033
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
[TBL] [Abstract][Full Text] [Related]
26. [Effect of recombinant human osteoprotegerin on osteoclasts stimulated by polyethylene particles].
Zhang H; Huang C; Chen S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):979-83. PubMed ID: 18773818
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro.
Xu F; Ye YP; Dong YH; Guo FJ; Chen AM; Huang SL
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):244-249. PubMed ID: 23592138
[TBL] [Abstract][Full Text] [Related]
28. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.
Hattersley G; Chambers TJ
Endocrinology; 1989 Apr; 124(4):1689-96. PubMed ID: 2924719
[TBL] [Abstract][Full Text] [Related]
29. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.
Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T
Endocrinology; 1996 May; 137(5):2187-90. PubMed ID: 8612568
[TBL] [Abstract][Full Text] [Related]
30. [Culture of human osteoclasts].
Ouyang GL; Yang QM; Deng LF; Xu FP; Zhu YP
Zhong Xi Yi Jie He Xue Bao; 2003 May; 1(1):57-61. PubMed ID: 15339621
[TBL] [Abstract][Full Text] [Related]
31. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
32. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
33. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro].
Ming LG; Wang MG; Chen KM; Zhou J; Han GQ; Zhu RQ
Yao Xue Xue Bao; 2012 Feb; 47(2):174-9. PubMed ID: 22512027
[TBL] [Abstract][Full Text] [Related]
34. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
35. The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
Piper K; Boyde A; Jones SJ
Calcif Tissue Int; 1994 Jan; 54(1):56-61. PubMed ID: 8118755
[TBL] [Abstract][Full Text] [Related]
36. The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro.
Zhang Y; Lin Y; Xiao L; Feng E; Wang W; Lin L
Regen Biomater; 2015 Sep; 2(3):197-202. PubMed ID: 26816641
[TBL] [Abstract][Full Text] [Related]
37. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
38. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
[TBL] [Abstract][Full Text] [Related]
39. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
[TBL] [Abstract][Full Text] [Related]
40. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
